Laetitia Decroix Guilloux

President Canada @Johnson & Johnson

Princeton, NJ, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Oct 2025 — Present

President Canada @Johnson & Johnson

View department →

Toronto, ON, CA

I oversee the full operations of the Innovation Medicine team in Canada with full P&L accountability. I am responsible for the strategic direction and financial health of the business, leading a team of over 450 employees. My role focuses on setting the organization for the future as well as driving growth, optimizing business processes, managing crises, and ensuring business continuity. Part of my duty is also to engage with key external stakeholders to support policy shaping.

EDUCATION

1996 — 2003

Faculté de Pharmacie Strasbourg

Dr, Pharmacy

2002 — 2003

ESC Dijon - Master in Management of Pharmaceutical Indutry

Master, Management

2018 — 2019

IFG Executive Education

Master of Business Administration - MBA, Entrepreneurship/Entrepreneurial Studies

2018 — 2019

University of Paris I: Panthéon-Sorbonne

Global Executive MBA, Business Administration and Management, General

ABOUT LAETITIA DECROIX GUILLOUX

With over 20 years in the pharmaceutical and healthcare industries, I’ve had the opportunity to create and lead high-performing teams and drive transformational growth across global markets. Specializing in oncology, hematology, and life sciences, I’ve worked in diverse environments, leading organizations through complex challenges and delivering sustainable, long-term success.Throughout my career, my focus has always been on creating strategic alignment across commercial, medical, regulatory, and operational functions. Whether in established markets, large (such as Germany, France US) or midsize or emerging regions like Turkey, Ukraine, Georgia, and Azerbaijan, I’ve been committed to driving market expansion and ensuring that innovative therapies reach those who need them most.My leadership approach centers around collaboration, empowerment, and fostering a shared sense of purpose within teams. I believe in creating environments where people feel supported and are given the autonomy to drive change. This has been key to successfully leading major transformations—turning underperforming units into market leaders and guiding organizations through periods of crisis, including political instability, natural disaster and economic volatility.I thrive in dynamic, fast-paced settings and have a proven track record of adapting to change, whether it\'s navigating regulatory landscapes, optimizing market access, or leading product development efforts. This adaptability has been a constant throughout my career, enabling me to successfully manage P&L, lead organizational restructures, and deliver business growth.I’ve also had the privilege of working at the intersection of innovation and R&D, where I’ve led the strategy and execution of oncology portfolios, from first in human, market entry to post-launch growth. My experience spans global commercial strategy and cross-functional leadership, making me adept at driving impactful decisions and aligning business objectives with long-term market trends.Ultimately, my mission is to create value through people, strategy, and innovation - while saving the lives of patients and to bring a better health for humanity. Whether it’s transforming teams, launching market-leading products, or developing solutions to complex challenges, I’m passionate about leading with purpose and helping businesses thrive in the face of change.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Laetitia Decroix Guilloux — President Canada at Johnson & Johnson in Princeton, NJ, US | Unifers